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The underlying relation between Parkinson’s disease
(PD) etiopathology and its major risk factor, aging, is
largely unknown. In light of the causative link be-
tween genome stability and aging, we investigate a
possible nexus between DNA damage accumulation,
aging, and PD by assessing aging-related DNA repair
pathways in laboratory animal models and humans.
We demonstrate that dermal fibroblasts from PD pa-
tients display flawed nucleotide excision repair (NER)
capacity and that Ercc1 mutant mice with mildly
compromised NER exhibit typical PD-like patholog-
ical alterations, including decreased striatal dopa-
minergic innervation, increased phospho-synuclein
levels, and defects in mitochondrial respiration.
Ercc1 mouse mutants are also more sensitive to the
prototypical PD toxinMPTP, and their transcriptomic
landscape shares important similarities with that of
PD patients. Our results demonstrate that specific
defects in DNA repair impact the dopaminergic sys-
tem and are associated with human PD pathology
and might therefore constitute an age-related risk
factor for PD.
INTRODUCTION
Parkinson’s disease (PD) is a common neurodegenerative disor-
der deranging the nigro-striatal circuits of the brain and particu-
larly dopaminergic (DA) neurons in the substantia nigra pars
compacta (SNpc). PD pathogenesis is complex and includes
alterations in multiple biological pathways. Defects in protein
quality and folding control, which culminate in the accumulation
of insoluble proteinaceous aggregates principally composed of
alpha-synuclein (a-syn), are critical in the disease progression.1866 Cell Reports 15, 1866–1875, May 31, 2016 ª 2016 The Author(s
This is an open access article under the CC BY-NC-ND license (http://Additional cardinal features of PD pathobiology are bioenergetic
anomalies—and specifically defects in mitochondrial respiratory
complex I (C-I)—and altered oxido-reductive (redox) state
(Greenamyre and Hastings, 2004). Simultaneous perturbation
of these pathways in specific functional domains of the brain
(e.g., the nigro-striatal system) constitutes a functional signature
of the disorder and a reference for modeling in laboratory
animals.
The vast majority of PD cases are idiopathic (typical PD), and
etiology is likely to be due to complex synergistic interactions be-
tween environmental factors—for instance, pesticide exposure
(Kamel et al., 2007)—and predisposing genotypes (GxE interac-
tions). The outcome of these interactions might be exacerbated
by aging, the single most important risk factor for PD (Chinta
et al., 2013; Collier et al., 2011). Studies on aging, however, are
laborious and extremely time-consuming, and consequently,
the specific molecular mechanisms underlying increased risk
for PD later in life remain largely unknown.
Aging is intrinsically associated with time-dependent accumu-
lation of macromolecular damage. Although the latter interests
virtually all biomolecules, accumulation of lesions in DNA is
particularly relevant. DNA is, in fact, at the apex of biological in-
formation hierarchy, and its modification can result in lasting,
transmittable, adverse consequences. Accordingly, DNA is the
sole biomolecule that can be repaired when damaged. Experi-
mental evidence in mutant mouse models and humans demon-
strated that derangement of specific DNA repair systems results
in dramatically accelerated wide-spread aging phenotypes and
progeroid syndromes that recapitulate essential features of
natural aging, albeit with a faster progression rate (Hoeijmakers,
2009).
The nucleotide excision repair (NER) system corrects forms of
DNA damage that cause severe structural deformations in the
double-helix, which can be caused by a remarkably diverse
range of lesions: UV-induced cyclobutane pyrimidine dimers
and 6-4 photoproducts; numerous chemical adducts; DNA-pro-
tein cross-links; intra-strand cross-links; and some forms of).
creativecommons.org/licenses/by-nc-nd/4.0/).
oxidative DNA damage (D’Errico et al., 2006; Nouspikel, 2008).
NER therefore constitutes the most-versatile repair mechanism,
and it is not surprising that congenital NER defects result in harsh
deterioration of cellular functions, leading to severe disorders.
On a molecular level, NER is orchestrated as a multi-step mech-
anism, composed of two converging branches: global genome-
and transcription coupled-NER (GG-NER and TC-NER, respec-
tively). GG-NER repairs an ample spectrum of helix-distorting
lesions genome-wide, whereas TC-NER repairs lesions that
block RNA polymerase and prevent transcription elongation. De-
fects in GG-NER, which underlie xeroderma pigmentosum (XP),
lead to broadly diffused accumulation of damage, enhanced
insurgence of mutations predisposing to (skin) cancer, and
neurological abnormalities in later life. Conversely, defects in
TC-NER interfere with a highly active process, transcription,
and elicit profound functional alterations favoring cell death
over carcinogenesis. In this case, the clinical outcome is dra-
matic, as in Cockayne syndrome (CS), and includes drastic neu-
rodevelopmental defects and accelerated aging (Hoeijmakers,
2009). Emerging evidence showing that NER also participates
in the repair of oxidative DNA damagemight be of particular rele-
vance for DA neurons in view of their physiologically oxidized
intracellular environment and of their pronounced vulnerability
to pro-oxidant insults (Guzman et al., 2010; Horowitz et al.,
2011).
Here, we investigated the nexus between aging and PD by
evaluating the possibility that defective NER might participate
to the etiopathology of this insidious disorder.
RESULTS
The collection of signs associated with NER defects includes
neurological symptoms in both humans and laboratory models,
and current experimental evidence supports the notion that
imperfect NER might constitute a general mechanism of neuro-
degeneration (Niedernhofer, 2008; Sepe et al., 2013). It is
unclear, however, whether NER derangement specifically con-
tributes to chronic neurodegeneration disorders and particularly
to PD. Moreover, NER relevance for the preservation of nigro-
striatal DA circuits has never been interrogated.
In silico analysis of expression profile datasets from open
repositories indicated that several NER genes are expressed
in the human SNpc (Sepe et al., 2013), yet functional evidence
determining NER importance for DA neurons was lacking. The
latter was assessed in a conditional mouse model with targeted
deletion of the key DNA repair gene Ercc1 in DA neurons. Ercc1
associates with its partner XPF to form an endonuclease central
to NER, and its ablation completely inactivates the pathway
(Weeda et al., 1997). Whereas Ercc1 has accessory functions
in other pathways than NER, the latter remains its main
domain of action. Moreover, mutations in Ercc1 cause a proge-
roid phenotype in also rodents, which does not manifest when
pure NER genes (e.g., XPA) are deleted, and Ercc1 mutants
are therefore informative models to investigate age-related
genomic instability to PD. Cre-recombinase:loxP (Cre-loxP) sys-
tem was used to generate mutants with targeted deletion in
dopamine transporter (DAT)-expressing neurons. Specificity of
Cre recombinase activity was validated using a lacZ reporterthat confirmed expression in DA neurons of the SNpc and not
in other cell types, such as serotonergic neurons of the Raphe
nucleus (Figure S1).
Ercc1/DAT-Cre+ mice are viable and normal at birth. At
26 weeks of age, specific deletion of Ercc1 in DA neurons mice
elicits reduction in tyrosine hydroxylase (TH) immunoreactivity
in the SNpc and in the striatum (Figures 1A and 1B). Aging pro-
foundly exacerbates SNpc DA neurons reduction, as evidenced
in 52-week-old Ercc1/DAT-Cre+ mice (Figure 1C). Damage is
limited in DA neurons and other populations remain unaffected,
as indicated by unchanged NeuN immunoreactivity (Figures 1A
and 1B). Overall, these findings demonstrate that Ercc1 function
and NER are essential to preserve integrity of the DA circuits
in time.
Ercc1/DAT-Cre+ mice provided proof-of-concept evidence
that Ercc1 function andNER are indispensable for the DA system
and might therefore be also relevant for PD. Data on patients’
peripheral cells, however, indicate that, in human PD, biological
anomalies are rather systemic (Schapira et al., 1989) and this
feature is not recapitulated in the Ercc1/DAT-Cre+ knockout
model, where the defect is confined to DA neurons. Whole-
body Ercc1 mutants, instead, might provide better information
on the human disorder. Complete ablation of Ercc1, however, re-
sults in an extremely aggressive phenotype modeling pathol-
ogies such as XP and CS (Hoeijmakers, 2009). These diseases
manifest in childhood, proceed rapidly, and have a very different
clinical presentation than that observed in late-onset, slow-pro-
gressing neurodegenerative disorders. We therefore focused
on a strain expressing one mutated allele, which generates a
severely, albeit not fully dysfunctional, truncated form of Ercc1,
in combination with a wild-type allele (Ercc1D/+). This particular
strain lacks an overt phenotype, has normal lifespan, and thus
constitutes a more-representative platform to investigate the
chronic, slow-progressing pathology of PD. At an age in which
wild-type animals do not present any DA alteration (20 weeks),
Ercc1D/+ mice already display functional evidence of DA injury
and decreased striatal DA innervation in particular (Figure 2A).
The latter is not paralleled by decreased DA number in the
SNpc (Figure 4B), and expression of the DA rate-limiting enzyme
TH protein expression is increased in Ercc1D/+ DA cell bodies
(Figure 2A). These observations suggest that this model features
an early and pre-symptomatic derangement of the DA system
in which only striatal terminals are affected and compensatory
mechanisms are ongoing (Greenwood et al., 1991).
Analyses of additional molecular indicators of PD progression
confirmongoingDAdysfunction inErcc1D/+. BecausePD is intrin-
sically associated with increased oxidation of the thiol/disulfide
redox couple in DA neurons (Mastroberardino et al., 2008,
2009), these equilibriawere studied inErcc1D/+ at single-cell level,
using imaging methods we previously developed (Horowitz et al.,
2011). SNpc DA neurons are indeed more oxidized in Ercc1D/+
(Figure 2B) whereas no sign of increased oxidation was detected
in hippocampal or Purkinje’s neurons (Figure S2A). These pertur-
bations are paralleled by increased gH2AX foci, specifically in DA
neurons, confirming both augmented DNA damage in Ercc1D/+
and the relevance of Ercc1 in double-strand breaks (DSB) repair
in vivo (Figure 2C). Ercc1D/+ mice also present increased ubiquiti-
nation levels and thus defects in protein homeostasis, albeit notCell Reports 15, 1866–1875, May 31, 2016 1867
Figure 1. NER Is Essential for the Integrity of the
DA System
(A) Targeted deletion of the key NER gene Ercc1 in DA
neurons results in degeneration of striatal DA pro-
cesses already evident in 26-week-old mice; DA neu-
rons (red) and the general neuronal population (green)
were revealed with anti-TH and anti-NeuN antibodies,
respectively. Inset shows clear reduction of TH+ neu-
rons in mutants.
(B) Loss of nigral DA neurons is paralleled by reduced
TH immunoreactivity in mutants’ striatum. Bar graphs
illustrate quantification of striatal TH immunoreactivity.
(C) Reduced TH+ neurons in SNpc and decreased
striatal TH immunoreactivity i is exacerbated at
52 weeks of age.
The scale bar represents 200 mm (A), 500 mm (B),
and 1,000 mm (C). Error bars on the graph denote SEM.
Six 26- and 52-week-old animals from each genotype
were used for each experiment.
1868 Cell Reports 15, 1866–1875, May 31, 2016
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exclusively in DA neurons andwithout impairment of proteasomal
activity (Figure 3A; see also Figure S2C). Conversely, total a-syn
levels are unchanged (Figure S2B). However, levels of phosphor-
ylated a-syn (p129S), which is the most-represented modified
species of a-syn within PD pathological inclusions (Anderson
et al., 2006), are higher in Ercc1D/+ SNpc (Figure 3B). These alter-
ations are paralleled by more-general signs of pathology such as
increased astrocyte activation in the SNpc and in the striatum of
mutant animals (Figures S3A and S3B).
Given the relevance of mitochondrial C-I defects in the etiopa-
thology of PD, its activity was evaluated in Ercc1D/+ mice by
measuring glutamate-malate-supported respiration in organ-
elles extracted from the ventral mesencephalon (VM). Both basal
(i.e., state 2 = state 4) and ADP-stimulated (i.e., state 3) respira-
tion is decreased inmutants (Figure 3C). Defects concern specif-
ically C-I because complex-II-driven respiration (i.e., supported
by succinate) is higher in Ercc1D/+ (Figure 3D), suggesting
ongoing compensatory mechanisms. Electron micrographs re-
vealed that functional defects are paralleled by morphological
abnormalities in Ercc1D/+ DA neurons’ mitochondria (Figure 3E).
Next-generation RNA sequencing (RNA-seq) and canonical
pathway analysis provided further mechanistic insights on the
consequences of NER inefficiency in the VM. RNA-seq revealed
460 differentially expressed genes (DEGs), 187 of which were
up- and 273 downregulated in Ercc1D/+ when compared to
matched wild-type controls. RNA-seq data were validated with
qPCR on 12 significantly up- or downregulated genes randomly
chosen among the most-significantly altered pathways (Fig-
ure S4; see also Table S3).
Differences between expression profiles of Ercc1D/+ and wild-
typematched controls were determined using overrepresentation
analysis (ORA) to highlight the significantly altered specific func-
tional categories (Figure 3F). As expected, the NER pathway is
downregulated in Ercc1D/+ (Figure 3G). Other modified pathways
included highly relevant processes for PD, including oxidative
phosphorylation, mitochondrial dysfunction, and proteasome.
Transcriptomic analysis therefore provided a strong unbiased
confirmation of the functional results obtained in our experiments,
showing altered intracellular redox state, bioenergetics defects,
(Figures 2B and 3C, respectively), and increased ubiquitination
levels (Figure 3A). Interestingly, a recent report has demonstrated
the involvement of EIF2-signaling pathway, which constitutes the
hit with highest significance in our analysis (Table S1), in both ge-
netic and sporadic forms of the disease (Mutez et al., 2014). Over-
all, these results further strengthen theconcept that inefficientNER
affects biological processes relevant for the DA system integrity.
The fundamental issue as to whether this specific combination
of pathways’ alterations reverberates human pathology, how-
ever, remained to be addressed. We therefore performed geneFigure 2. Alterations in the Nigro-striatal DA System in Ercc1D/+ Mice
(A) Decreased striatal DA innervation in the caudate putamen (CPu) of Ercc1D/+ mic
the right side represent the quantification of the fluorescent signal.
(B) Increased oxidation in the SS/SH redox couple in SNpc DA neurons. The mont
automatically defines regions of interest (ROIs) by using the TH signal as a mask
(C) Ercc1D/+ mutants feature increased DNA damage as indicated by the higher
The scale bar represents 500 mm (A) and 150 mm (B). *p < 0.05; **p < 0.01; unpaired
genotype were used in each experiment.
1870 Cell Reports 15, 1866–1875, May 31, 2016set enrichment analysis (GSEA) using gene collections as defined
by the Kyoto Encyclopedia of Genes and Genomes (KEGG)
and reducing intrinsic redundancy in pathways databases. We
compared Ercc1D/+ RNA-seq dataset with publicly available da-
tasets from human PD and incidental Lewy body disease (ILBD)
SNpc, which is regarded as a pre-symptomatic form of PD
(DelleDonne et al., 2008). Of the 12 pathways downregulated in
Ercc1D/+, five are shared with ILBD and/or PD and include very
relevant processes for PD, such as oxidative phosphorylation,
glutathione metabolism, and proteasome (Figure 3G). As ex-
pected, the gene set KEGG_PARKINSONS_DISEASE (http://
www.broadinstitute.org), which was consolidated with the
KEGG_HUNTINGTONS_DISEASE pathway after redundancy
reduction, is downregulated in all datasets, further emphasizing
objective affinities between ourmousemodel and the humandis-
ease. Of the 17 upregulated pathways in Ercc1D/+, seven are
shared with PD and none with ILBD. Of note, only one pathway
is shared between ILBD and PD (Figure 3H). Common upregu-
lated pathways include inflammation and mitogen-activated
protein kinase (MAPK) signaling, which are both very relevant
for human PD (Deleidi and Gasser, 2013; Horowitz et al., 2011;
Lin et al., 2008). In summary, transcriptomics analyses highlight
important molecular similarities between Ercc1D/+ mice and the
human disease and substantiate our findings showing functional
alterations in mitochondrial function, intracellular redox state,
and increased ubiquitination in the VM.
Enrichment factors calculation (EF) was used to explore
further affinities between Ercc1D/+ and human PD. EF estimates
similarity between datasets by comparing the extent of abun-
dance of common elements in the groups under consideration
(e.g., Ercc1D/+ and PD) with the extent of abundance that would
be expected in random groups. The number of common down-
regulated pathways in related pathologies such as PD and
ILBD is 4.2 times more abundant than what expected by chance
(p < 107; Table S2). Downregulated pathways common to
Ercc1D/+ and PD and to Ercc1D/+ and ILBD are, respectively,
6.7 and 5.6 more abundant than what would be expected by
chance (p < 104). We did not observe a significant enrichment
in upregulated processes shared between Ercc1D/+ and ILBD,
whereas we did observe a 2-fold enrichment (p < 0.0005) when
comparing Ercc1D/+ and PD. As expected, the number of com-
mon upregulated pathways between both PD and ILBD human
datasets was 9.2 times more abundant than what would be
expected by chance (p < 104). These additional analyses further
confirm affinities between the transcriptional landscape of
Ercc1D/+ and human PD.
Elements such as (1) decreased striatal TH innervation without
significant differences in DA nigral cell bodies, (2) increased
phospho-synuclein levels without detectable aggregates, ande is paralleled by increased TH expression in SNpc neuronal bodies. Graphs on
age on the right side represents a zoom showing how the Metamorph software
. ROIs are then transferred to the image expressing the SS/SH ratio.
proportion of DA neurons containing more than five gH2AX foci per nucleus.
t test. Error bars on the graph denote SEM. Six 20-week-old animals from each
Figure 3. Ercc1D/+ Mice Display Hallmarks of PD Pathology and Share Similarities with PD Patients
(A) Increased ubiquitination in the SNpc and in its DA neurons. The corresponding graph expresses intensity of the ubiquitin signal in TH+ regions of the image.
(B) Increased phosphorylation of a-syn at ser129 (p-syn) in both cell bodies (arrows) and processes (arrowheads) of SNpc DA neurons. Graph expresses intensity
of the p-syn signal in TH+ regions.
(C) Impaired C-I-driven mitochondrial respiration in Ercc1D/+ mice. When energized with glutamate/malate, mitochondria extracted from the VM region of
Ercc1D/+ mice exhibit decreased respiration in both state 4 and state 3.
(D) Conversely, succinate-stimulated respiration is increased in both state 4 and state 3 in mitochondria extracted from the VM region of Ercc1D/+ animals.
(E) Ultrastructural electron microscopy reveals abnormal mitochondria with disorganized cristae in Ercc1D/+ SNpc DA neurons. DA neurons are unambiguously
identified by precipitated electron-dense DAB resulting from pre-embedding TH immunostaining. ER, endoplasmic reticulum; M, mitochondria.
(legend continued on next page)
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Figure 4. Increased Sensitivity of Ercc1D/+
Mice to MPTP and Inefficient NER in PD
Patients’ Fibroblasts
(A) Decrease in striatal DA innervation induced by
MPTP treatment is more pronounced in Ercc1D/+
mice.
(B) Unbiased stereological counts indicating more
severe MPTP-induced DA loss in Ercc1D/+ mice.
The scale bar represents 500 mm (A) and 200 mm
(B). *p < 0.05; two-way ANOVA. Error bars on
the graph denote SEM. For the experiment, five
20-week-old animals for each group were used.
(C) Mild NER defects in fibroblasts derived from
idiopathic (iPD; n = 11) and genetic (LRRK2-PD;
n = 4) PD patients, but not from AD cases, as
measured by UDS assay. Genetic PD cells harbor
either the G2019S (n = 2) or the R1441G (n = 2)
mutation. *p < 0.05; **p < 0.01; one way ANOVA.
No significant differences were detected in cells
derived from AD patients (n = 4). Box and whis-
kers representation also shows the mean of the
values (+).
(D) DSB repair efficiency was evaluated in PD and
AD fibroblasts. PD cases did not differ from control
cases 1 hr after exposure to gamma irradiation
(2 Gy), whereas they exhibited a significant in-
crease in the number gH2AX foci still present
24 hr after irradiation (left graph), which suggests
impaired DSB repair capacity. AD cases did not
present significant differences from respective,
matched controls *p < 0.05; two-way ANOVA.
Error bars on graph represent SEM.(3) absence of overt symptoms suggest that Ercc1D/+ micemight
represent a pre-symptomatic model predisposed to DA degen-
eration upon detrimental GxE interactions. To explore possible
synergies between ineffective DNA repair and environmental
chemicals associated with PD, we exposed Ercc1D/+ mice to
the prototypical PD toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydro-(F) RNA-seq and subsequent canonical pathway analysis reveals that pathways highly relevant for PD patho
(G) Heatmap comparing downregulated (green) and upregulated (red) pathways in Ercc1D/+ mice, in PD, and
(H) Venn diagrams showing the number of common downregulated and upregulated pathways in Ercc1D/+,
The scale bar represents 15 mm (A and B) and 0.6 mm (C). *p < 0.05; ***p < 0.001; **p < 0.01; unpaired t test. Erro
eight (C and D) 20-week-old animals for each genotype were used in each experiment.
1872 Cell Reports 15, 1866–1875, May 31, 2016pyridine (MPTP). As expected, 3 days
MPTP treatment induced a significant
decrease in striatal TH immunoreactivity
as well as in DA neuronal bodies in the
SNpc (Figures 4A and 4B). Neurodegen-
eration, however, was more pronounced
in Ercc1D/+, which suffered a 12% loss
in nigral DA cell number when compared
to vehicle-treated littermates, against
the 7.5% loss observed in wild-type ani-
mals. Of note, the extent of degenera-
tion in these experiments, which are per-
formed in a genetically uniform C57BL/
6:FVB F1 hybrid background, is in agree-
ment with previous reports indicatingMPTP resistance in the FVB background (Liu et al., 2003).
DA innervation in the striatum after MPTP was also lower in
Ercc1D/+.
The possibility that NER may be functionally deranged in
human PD was finally evaluated by assaying unscheduled DNA
synthesis (UDS) in patients. UDS quantifies NER by monitoringgenesis are altered in Ercc1D/+ VM.
in ILBD.
PD, and human ILBD.
r bars on the graph denote SEM. Six (A, B, and E) to
DNA synthesis after damage in cells outside S phase, therefore
in stages in which DNA synthesis is unambiguously associated
with repair. DNA damage is generated by UV-C exposure
(16 J/m2), which creates lesions specifically amended by NER:
6-4 photoproducts and pyrimidine dimers. DNA synthesis is
measured by incorporation of labeled precursors that can be
subsequently detected using copper(I)-catalyzed azide-alkyne
cycloaddition (or ‘‘click chemistry’’) of fluorescent molecules
(Salic and Mitchison, 2008). UDS revealed reduced NER capac-
ity in both idiopathic and genetic (LRRK2 G2019S or R1441G)
patients, particularly in those carrying the LRRK2 mutation (Fig-
ure 4C; see also Table S4). Of note, this magnitude of UDS
decrease is comparable to that previously reported in Ercc1D/+
fibroblasts (Weeda et al., 1997) and further substantiates the af-
finities between this mouse strain and PD. Conversely, fibro-
blasts from AD patients do not exhibit any significant difference
in NER capacity, at least under these conditions (Figure 4D).
DNA repair pathways functionally interact and, for instance,
the critical NER gene Ercc1 also facilitates DNA DSB and inter-
strand cross-link repair (Ahmad et al., 2008). We therefore
analyzed how these specific lesions are repaired in PD and
Alzheimer’s disease (AD) fibroblasts by evaluating the number
of gH2AX foci after gamma irradiation. Whereas we did not
observe differences in the formation of foci between the different
groups, PD fibroblasts exhibited decreasedDSB repair capacity,
evidenced by the persistence of foci 24 hr after irradiation (Fig-
ure 4D). Overall, these results demonstrate a systemic defect
in DNA repair in PD patients.
DISCUSSION
Traditionally, investigations on DNA damage and PD have been
circumscribed to mtDNA, whereas nuclear DNA (nuDNA) only
received modest attention. Impact of nuDNA lesions’ on cell
function, however, may largely exceed that of mtDNA damage.
nuDNA is in fact present in a single copy, whereas cells contain
hundreds of mtDNA copies, and in post-mitotic neurons, nuDNA
integrity must be preserved lifelong. Here, we demonstrate that
the presence of a truncated Ercc1 allele is sufficient to cause
mild derangement of the nuDNA repair machinery in rodents,
which in turn elicits anomalies typical of PD. Although Ercc1 is
involved in other DNA repair processes than NER, the latter re-
mains its principal domain of action and it is therefore appro-
priate to infer that deranged NER is responsible, at least in
part, for the observed PD-related anomalies in the DA system.
Consistently, peripheral cells of genetic and idiopathic human
PD cases display defective NER. It is, however, likely that other
nuDNA repair pathways might participate to PD etiopathogene-
sis, and further studies will be necessary to achieve a full charac-
terization. Nonetheless, our work addresses a gap concerning
the relevance of nuDNA stability in PD and lays foundation for
further investigations. Because deranged NER recapitulates
essential aspects of natural aging in laboratory models and hu-
mans, our study also establishes a mechanistic nexus between
PD and its principal risk factor.
Increased vulnerability of PD peripheral cells to DNA damage
has been already described a long time ago in a studymonitoring
cell viability after X-rays exposure (Robbins et al., 1985). X-rays,however, induce a broad spectrum of DNA lesions, including
double- and single-strand breaks, and therefore do not allow
identification of the specific defective repair pathway. UV-C, in
contrast, circumscribes lesion type to bulky distortions, which
are specifically amended by NER; on these premises, our exper-
iments demonstrate unambiguously functional NER defects in
PD. This evidence is of profound relevance given the causative
association between NER and aging (Hoeijmakers, 2009), and
it also implies that reduced NER efficiency could potentiate other
detrimental GxE interactions to initiate pathogenesis. UDS
experiments demonstrate that NER defects tend to be more
pronounced in LRRK2 fibroblasts, which also display smaller
variability when compared to cells from idiopathic cases. The
reasons underlying these subtle differences are obscure and
should be investigated in future studies. It is tempting to specu-
late, however, that mutations in LRRK2 might directly compro-
mise the process of DNA repair. A recent report focused on
mtDNA indeed established a link between LRRK2 mutations
and DNA damage (Sanders et al., 2014a).
Further relevance of NER for the DA system integrity stems
from its ability to amend also oxidative modifications in the dou-
ble helix. Bulky structural distortions in DNA, which constitute
the essential prerequisite for NER, can in fact also be caused
by oxidative damage (D’Errico et al., 2006). In addition, recent re-
ports demonstrate a cross-talk between NER and other repair
pathways, including base excision repair, which is the preferred
mechanism to correct oxidative lesions (Pascucci et al., 2011).
Because of their distinctive physiology, DA neurons feature a
relatively oxidized intracellular redox state, even in unstressed
physiological conditions (Guzman et al., 2010; Horowitz et al.,
2011), and PD pathogenesis is characterized by progressive
oxidation of these cells (Mastroberardino et al., 2008). It is there-
fore conceivable that adequate repair systems to amend oxida-
tive modifications are of particular importance to preserve
genomic integrity in this specific neuronal population. Efficient
repair of oxidative lesions has even greater significance in
consideration of PD environmental risk factors, which principally
include pro-oxidant pesticides (Kamel et al., 2007). Here, defec-
tive repair and consequent loss of fidelity in the genetic informa-
tion could constitute modifiers sensitizing the DA system to envi-
ronmental hazards and therefore predisposing to PD. Indeed, a
very recent report demonstrates that oxidative mtDNA damage
induced by the C-I inhibitor rotenone is detectable prior to any
sign of degeneration (Sanders et al., 2014b). Our data demon-
strate higher sensitivity of NER-deficient mice to the prototypical
PD toxin MPTP and indicate that inefficient DNA repair may be a
risk factor for PD. This is also supported by preliminary epidemi-
ological investigations in small cohorts of idiopathic PD patients,
demonstrating association with SNPs in some DNA repair genes
(Cornetta et al., 2013; Gencer et al., 2012). At present, none of
these variants interests genes in NER; the found variants, how-
ever, might certainly influence proper NER in consideration
of complex cross-talk between the high number of proteins
involved in DNA repair—some of which may have additional
and often poorly characterized functions. Additional investiga-
tions focused on specific NER genes, and eventually analyzing
cohorts with ascertained exposure to pro-oxidant pesticides,
will unravel possible genetic associations with PD. Finally,Cell Reports 15, 1866–1875, May 31, 2016 1873
additional studies to determine synergism between mutations in
genes associated with monogenic forms of PD (e.g., a-syn) and
deranged NER are warranted.
In conclusion, our study demonstrated the relevance of
nuDNA repair, and of NER in particular, for PD and suggests
that aging-related genomic instability may constitute a genetic
modifier predisposing to PD.
EXPERIMENTAL PROCEDURES
Human Dermal Fibroblasts
Primary human dermal fibroblasts from healthy and idiopathic PD patients
were obtained as previously described (Ambrosi et al., 2014); clinical data
are summarized in Table S4. Genetic PD (catalog ID ND32975, ND32976,
ND32970, and ND33879) and AD fibroblasts and matched controls (catalog
ID AG05810, AG07872, AG07936, AG08125, AG08269, AG08527, AG08543,
and AG21158) were obtained from the Cell Repositories of the Coriell Institute
for Medical Sciences (http://ccr.coriell.org/sections/search/).
UDS Assay
Cells were irradiated with UV-C 16 J/m2 and then incubated with F10 medium
supplemented with 10% dialyzed serum, 20 mM 5-ethynyl-20-deoxyuridine
(EdU), and 1 mM 5-fluoro-20-deoxyuridine (FUrd) for 3 hr. Cells were then fixed
and processed using the Click-iT EdU Alexa Fluor 594 Imaging Kit (Invitrogen).
DSB Analysis
Primary fibroblasts were seeded on glass coverslips at a concentration of 105
cells/well and exposed to a 2 Gy g-irradiation dose (Cesium-137 source;
Gammacell 40 low-dose rate laboratory irradiator; Nordion). DSBs were de-
tected using a mouse monoclonal anti-phospho-histone H2AX antibody
(anti-gH2AX - s139; 1:1,000; 05336; Millipore).
Animals
NER Ercc1D/+ mouse mutants generation and characterization has been pre-
viously described (Weeda et al., 1997). Ercc1D/+ mice are in a FVB:C57BL/6J
(50:50) background. Animals were kept on a regular diet and housed at the An-
imal Resource Center (Erasmus University Medical Center), which operates in
compliance with the ‘‘Animal Welfare Act’’ of the Dutch government, following
the ‘‘Guide for the Care and Use of Laboratory Animals’’ as its standard.
MPTP Treatment
Mice were injected with 20 mg/kg of MPTP (M0986; Sigma-Aldrich) or saline
(vehicle) intraperitoneally (i.p.) every 2 hr for a total of four injections, resulting
in a cumulative dose of 80 mg/kg. Animals were sacrificed 3 days after
treatment.
Immunofluorescence
Immunofluorescence (IF) was carried out according to standard procedures.
Details andantibodiesaredescribed inSupplementalExperimental Procedures.
Electron Microscopy
Vibratome cut 100-mm-thick sections were processed for immunochemistry
with a mouse monoclonal anti-TH (1:4,000; Millipore; MAB318). Signal was re-
vealed with 3,30-diaminobenzidine (DAB). Slices were post-fixed in 1% OsO4
and flat embedded in Epon 812 (TAAB). Ultrathin sections were obtained
with a Reichert Ultracut S ultramicrotome, contrasted with uranyl acetate
and lead citrate, and observed in a Philips CM120 electron microscope.
Thiol/Disulfide Histochemistry
Histological labeling of thiol/disulfides was performed as previously described
(Horowitz et al., 2011).
Bioenergetics Assays
Bioenergetics assays were performed in an XF-24 Extracellular Flux Analyzer
(Seahorse Bioscience), using 10 mg of mitochondrial protein. C-I-driven respi-1874 Cell Reports 15, 1866–1875, May 31, 2016ration was sustained by glutamate (2 mM) and malate (2 mM); complex-II-
driven respiration was sustained by succinate (10 mM); in the latter case, rote-
none (4 mM) was added to inhibit C-I and prevent reversed electron transfer
from succinate to nicotinamide adenine dinucleotide (NAD+).
mRNA Sequencing
Sample preparation from total RNA was performed using the TruSeq mRNA
sample preparation kit (Illumina) according to the manufacturer’s protocols
and sequenced in one lane each of a HiSeq2500 (Illumina).
mRNA-Seq Analysis
Reads were aligned to the mouse reference genome (mm9) using Tophat
(version 1.3.1.Linux_x86_64,–coverage-search, -butterfly-search,–segment-
mismatches 1,–segment-length 18) via the NARWHAL (Brouwer et al.,
2012) automation software. SAMMate (http://sammate.sourceforge.net/; Xu
et al., 2011) was used to detect and quantify transcripts. Gene counts
were calculated taking into account the reads mapped on exons or on
exon-exon junctions. DEGs were detected using the R package EdgeR (Rob-
inson et al., 2010). An over-dispersed Poisson model was used to account
for biological and technical variability. Genes with a false discovery rate
(FDR) of <0.05 and fold change ± 1.5 were considered to be differentially
expressed.
Statistical Analysis
Experiments were performed in four to six independent biological replicates.
Comparison of multiple groups was performed by ANOVA or Kruskal-Wallis
test; comparisons between two groups were performed by t test.
ACCESSION NUMBERS
The accession number for the datasets reported in this paper is GEO:
GSE75000.
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http://dx.doi.org/10.1016/j.celrep.2016.04.071.
AUTHOR CONTRIBUTIONS
S.S. performed research with the help of C.M. and S.G. W.F.J.v.I. performed
next-generation RNA-seq, K.W.J.D. assembled the NGS data, and C.P.-G.
performed bioinformatics analyses. Y.M.A.R. generated the conditional mu-
tants. A.L.N. assisted with 4Pi microscopy. S.C. and F.B. performed unbiased
stereological counts. J.H.J.H. contributed to study design. P.G.M., S.S., and
C.M. wrote themanuscript. All the authors provided intellectual input and over-
all assistance in designing and executing the study and in compiling the manu-
script. P.G.M. conceived, designed, and directed the study.
ACKNOWLEDGMENTS
P.G.M. was supported by a grant from the Netherlands Genomics Initiative
(NGI/NWO 05040202), a Marie Curie grant (IRG 247918), and the CEREBRAD
grant under the EU-FP7 framework (project number 295552). The Extracellular
Flux Analyzer by Seahorse Bioscience was purchased thanks to a generous
donation from Dorpmans-Wigmans Stichting (to P.G.M.). J.H.J.H. acknowl-
edges financial support from the NIH/National Institute of Aging (1PO1 AG-
17242-02), the National Institute of Environmental Health Sciences (1UO1
ES011044), the Royal Academy of Arts and Sciences of the Netherlands
(academia professorship), and a European Research Council Advanced Grant.
C.M. was supported by the Ri.MED Foundation. The research leading to these
results has received funding from the European Community’s Seventh Frame-
work Programme (FP7/2007-2013) under grant agreement no. HEALTH-F2-
2010-259893. C.P.G. is supported by ERACOL.
Received: August 20, 2015
Revised: February 1, 2016
Accepted: April 19, 2016
Published: May 19, 2016
REFERENCES
Ahmad, A., Robinson, A.R., Duensing, A., van Drunen, E., Beverloo, H.B.,
Weisberg, D.B., Hasty, P., Hoeijmakers, J.H., and Niedernhofer, L.J. (2008).
ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol.
Cell. Biol. 28, 5082–5092.
Ambrosi, G., Ghezzi, C., Sepe, S., Milanese, C., Payan-Gomez, C., Bombar-
dieri, C.R., Armentero, M.T., Zangaglia, R., Pacchetti, C., Mastroberardino,
P.G., and Blandini, F. (2014). Bioenergetic and proteolytic defects in fibro-
blasts from patients with sporadic Parkinson’s disease. Biochim. Biophys.
Acta 1842, 1385–1394.
Anderson, J.P., Walker, D.E., Goldstein, J.M., de Laat, R., Banducci, K., Cac-
cavello, R.J., Barbour, R., Huang, J., Kling, K., Lee, M., et al. (2006). Phosphor-
ylation of Ser-129 is the dominant pathological modification of alpha-synuclein
in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739–29752.
Brouwer, R.W., van den Hout, M.C., Grosveld, F.G., and van Ijcken, W.F.
(2012). NARWHAL, a primary analysis pipeline for NGS data. Bioinformatics
28, 284–285.
Chinta, S.J., Lieu, C.A., Demaria, M., Laberge, R.M., Campisi, J., and Ander-
sen, J.K. (2013). Environmental stress, ageing and glial cell senescence: a
novel mechanistic link to Parkinson’s disease? J. Intern. Med. 273, 429–436.
Collier, T.J., Kanaan, N.M., and Kordower, J.H. (2011). Ageing as a primary risk
factor for Parkinson’s disease: evidence from studies of non-human primates.
Nat. Rev. Neurosci. 12, 359–366.
Cornetta, T., Patrono, C., Terrenato, I., De Nigris, F., Bentivoglio, A.R., Testa,
A., Palma, V., Poggioli, T., Padua, L., and Cozzi, R. (2013). Epidemiological,
clinical, and molecular study of a cohort of Italian Parkinson disease patients:
association with glutathione-S-transferase and DNA repair gene polymor-
phisms. Cell. Mol. Neurobiol. 33, 673–680.
D’Errico, M., Parlanti, E., Teson, M., de Jesus, B.M., Degan, P., Calcagnile, A.,
Jaruga, P., Bjøra˚s, M., Crescenzi, M., Pedrini, A.M., et al. (2006). New functions
of XPC in the protection of human skin cells from oxidative damage. EMBO J.
25, 4305–4315.
Deleidi, M., and Gasser, T. (2013). The role of inflammation in sporadic and fa-
milial Parkinson’s disease. Cell. Mol. Life Sci. 70, 4259–4273.
DelleDonne, A., Klos, K.J., Fujishiro, H., Ahmed, Z., Parisi, J.E., Josephs, K.A.,
Frigerio, R., Burnett, M., Wszolek, Z.K., Uitti, R.J., et al. (2008). Incidental Lewy
body disease and preclinical Parkinson disease. Arch. Neurol. 65, 1074–1080.
Gencer, M., Dasdemir, S., Cakmakoglu, B., Cetinkaya, Y., Varlibas, F., Tireli,
H., Kucukali, C.I., Ozkok, E., and Aydin, M. (2012). DNA repair genes in
Parkinson’s disease. Genet. Test. Mol. Biomarkers 16, 504–507.
Greenamyre, J.T., and Hastings, T.G. (2004). Biomedicine. Parkinson’s–diver-
gent causes, convergent mechanisms. Science 304, 1120–1122.
Greenwood, C.E., Tatton, W.G., Seniuk, N.A., and Biddle, F.G. (1991).
Increased dopamine synthesis in aging substantia nigra neurons. Neurobiol.
Aging 12, 557–565.
Guzman, J.N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schu-
macker, P.T., and Surmeier, D.J. (2010). Oxidant stress evoked by pace-
making in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696–700.
Hoeijmakers, J.H. (2009). DNA damage, aging, and cancer. N. Engl. J. Med.
361, 1475–1485.
Horowitz, M.P., Milanese, C., Di Maio, R., Hu, X., Montero, L.M., Sanders, L.H.,
Tapias, V., Sepe, S., van Cappellen, W.A., Burton, E.A., Greenamyre, J.T., and
Mastroberardino, P.G. (2011). Single-cell redox imaging demonstrates a
distinctive response of dopaminergic neurons to oxidative insults. Antioxid.
Redox Signal. 15, 855–871.Kamel, F., Tanner, C., Umbach, D., Hoppin, J., Alavanja, M., Blair, A., Comyns,
K., Goldman, S., Korell, M., Langston, J., et al. (2007). Pesticide exposure and
self-reported Parkinson’s disease in the agricultural health study. Am. J. Epi-
demiol. 165, 364–374.
Lin, E., Cavanaugh, J.E., Leak, R.K., Perez, R.G., and Zigmond, M.J. (2008).
Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopami-
nergic cells. J. Neurosci. Res. 86, 108–117.
Liu, L., Hsu, S.S., Kalia, S.K., and Lozano, A.M. (2003). Injury and strain-depen-
dent dopaminergic neuronal degeneration in the substantia nigra of mice after
axotomy or MPTP. Brain Res. 994, 243–252.
Mastroberardino, P.G., Orr, A.L., Hu, X., Na, H.M., and Greenamyre, J.T.
(2008). A FRET-based method to study protein thiol oxidation in histological
preparations. Free Radic. Biol. Med. 45, 971–981.
Mastroberardino, P.G., Hoffman, E.K., Horowitz, M.P., Betarbet, R., Taylor, G.,
Cheng, D., Na, H.M., Gutekunst, C.A., Gearing, M., Trojanowski, J.Q., et al.
(2009). A novel transferrin/TfR2-mediated mitochondrial iron transport system
is disrupted in Parkinson’s disease. Neurobiol. Dis. 34, 417–431.
Mutez, E., Nkiliza, A., Belarbi, K., de Broucker, A., Vanbesien-Mailliot, C.,
Bleuse, S., Duflot, A., Comptdaer, T., Semaille, P., Blervaque, R., et al.
(2014). Involvement of the immune system, endocytosis and EIF2 signaling
in both genetically determined and sporadic forms of Parkinson’s disease.
Neurobiol. Dis. 63, 165–170.
Niedernhofer, L.J. (2008). Nucleotide excision repair deficient mouse models
and neurological disease. DNA Repair (Amst.) 7, 1180–1189.
Nouspikel, T. (2008). Nucleotide excision repair and neurological diseases.
DNA Repair (Amst.) 7, 1155–1167.
Pascucci, B., D’Errico, M., Parlanti, E., Giovannini, S., and Dogliotti, E. (2011).
Role of nucleotide excision repair proteins in oxidative DNA damage repair: an
updating. Biochemistry (Mosc) 76, 4–15.
Robbins, J.H., Otsuka, F., Tarone, R.E., Polinsky, R.J., Brumback, R.A., and
Nee, L.E. (1985). Parkinson’s disease and Alzheimer’s disease: hypersensitiv-
ity to X rays in cultured cell lines. J. Neurol. Neurosurg. Psychiatry 48, 916–923.
Robinson, M.D., McCarthy, D.J., and Smyth, G.K. (2010). edgeR: a Bio-
conductor package for differential expression analysis of digital gene expres-
sion data. Bioinformatics 26, 139–140.
Salic, A., and Mitchison, T.J. (2008). A chemical method for fast and sensitive
detection of DNA synthesis in vivo. Proc. Natl. Acad. Sci. USA 105, 2415–2420.
Sanders, L.H., Laganie`re, J., Cooper, O., Mak, S.K., Vu, B.J., Huang, Y.A., Pa-
schon, D.E., Vangipuram, M., Sundararajan, R., Urnov, F.D., et al. (2014a).
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural
cells from Parkinson’s disease patients: reversal by gene correction. Neuro-
biol. Dis. 62, 381–386.
Sanders, L.H., McCoy, J., Hu, X., Mastroberardino, P.G., Dickinson, B.C.,
Chang, C.J., Chu, C.T., Van Houten, B., and Greenamyre, J.T. (2014b). Mito-
chondrial DNA damage: molecular marker of vulnerable nigral neurons in
Parkinson’s disease. Neurobiol. Dis. 70, 214–223.
Schapira, A.H., Cooper, J.M., Dexter, D., Jenner, P., Clark, J.B., and Marsden,
C.D. (1989). Mitochondrial complex I deficiency in Parkinson’s disease. Lancet
1, 1269.
Sepe, S., Payan-Gomez, C., Milanese, C., Hoeijmakers, J.H., and Mastrober-
ardino, P.G. (2013). Nucleotide excision repair in chronic neurodegenerative
diseases. DNA Repair (Amst.) 12, 568–577.
Weeda, G., Donker, I., de Wit, J., Morreau, H., Janssens, R., Vissers, C.J.,
Nigg, A., van Steeg, H., Bootsma, D., and Hoeijmakers, J.H. (1997). Disruption
ofmouse ERCC1 results in a novel repair syndromewith growth failure, nuclear
abnormalities and senescence. Curr. Biol. 7, 427–439.
Xu, G., Deng, N., Zhao, Z., Judeh, T., Flemington, E., and Zhu, D. (2011).
SAMMate: a GUI tool for processing short read alignments in SAM/BAM
format. Source Code Biol. Med. 6, 2.Cell Reports 15, 1866–1875, May 31, 2016 1875
